UNITE glioblastoma

Understanding and targeting resistance in glioblastoma

We aim to develop concepts to predict and monitor treatment response and failure, and ultimately, to discover novel therapies for glioblastoma patients

More about UNITE
Link to: Research
Brain Tumor scaled

UNITE School of Neurooncology

Member Teaser Image

MEMBERS

UNITE Glioblastoma brings together physician-scientists and scientists from Heidelberg University Hospital, University Hospital Mannheim, the German Cancer Research Center and Mannheim University of Applied Sciences.

EVENTS

UNITE coordinates regular seminars and symposia with internal and external speakers presenting the latest research findings in glioblastoma research.

Event Teaser Image

Participating Institutions

uniklinikHD Neuro6771carinakircher

Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial

Research findings related to UNITE work packages A01/A03/A06/B01/B04/C01/C02 Advances in molecular understanding and diagnostic precision of glioblastoma enable the identification of key genetic…
uniklinikHD Neuro6762carinakircher scaled e1780386352196

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen

Research findings related to UNITE work packages A03/B01/B03 T cell receptor-engineered T cells (TCR-T) could be advantageous in glioblastoma by allowing safe and ubiquitous targeting of the glioblastoma-derived…
uniklinikHD Neuro6272carinakircher

Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing

Research findings related to UNITE work packages A06/A07/B06N Glioblastomas are invasive brain tumors with high therapeutic resistance. Neuron-to-glioma synapses have been shown to promote glioblastoma…